BHAGCHEM — Bhagiradha Chemicals and Industries Balance Sheet
0.000.00%
- IN₹31.80bn
- IN₹33.55bn
- IN₹4.40bn
Annual balance sheet for Bhagiradha Chemicals and Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.88 | 30.2 | 38.6 | 494 | 298 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 613 | 998 | 1,300 | 1,166 | 2,110 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,141 | 1,739 | 2,283 | 2,803 | 3,749 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,537 | 1,609 | 2,008 | 2,794 | 5,310 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,732 | 3,420 | 4,469 | 5,760 | 9,332 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 951 | 1,327 | 1,008 | 1,255 | 1,953 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,175 | 1,522 | 1,337 | 1,623 | 2,509 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,557 | 1,899 | 3,132 | 4,137 | 6,822 |
| Total Liabilities & Shareholders' Equity | 2,732 | 3,420 | 4,469 | 5,760 | 9,332 |
| Total Common Shares Outstanding |